Filing Details

Accession Number:
0000950170-23-071689
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-19 20:37:37
Reporting Period:
2023-12-19
Accepted Time:
2023-12-19 20:37:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759138 Cabaletta Bio Inc. CABA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1791742 Gwendolyn Binder C/O Cabaletta Bio, Inc.
2929 Arch Street, Suite 600
Philadelphia PA 19104
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-19 11,000 $1.01 31,000 No 4 M Direct
Common Stock Disposition 2023-12-19 7,868 $21.76 23,132 No 4 S Direct
Common Stock Disposition 2023-12-19 3,132 $22.22 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-12-19 11,000 $0.00 11,000 $1.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
111,756 2028-10-28 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.05 - $22.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.06 - $22.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter.